Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
425 Leser
Artikel bewerten:
(2)

Veterinary Brain Surgery at the Veterinary Referral Center of Central Oregon Delivers Exceptional Results

Complex veterinary procedure restores health and qualify of life, offering new hope to pet-parents facing complicated neurological disorders

BEND, OREGON / ACCESSWIRE / January 14, 2025 / The Veterinary Referral Center of Central Oregon is known for advanced veterinary care including emergency and specialty medical services. Their hospital and highly trained staff give difficult cases the technology and expertise needed to achieve results that may otherwise not be possible. One recent example is a case that arrived at VRCCO in July of 2024.

Kai, a 6-year-old Cocker Spaniel, came to VRCCO to meet with board-certified, veterinary Neurologist Dr. Annie Chen-Allen, DVM, MS, Dip ACVIM after experiencing months of vestibular symptoms including a head tilt and balance issues. His symptoms originally seemed to improve with medication provided by his family veterinarian; however, Kai eventually regressed into a more severe head tilt along with balance issues and mentation changes that worried his pet-parents.

With the advent of high-quality brain imaging, VRCCO had the opportunity and knowledge to give Kai a more accurate diagnosis and provide the best treatment options available to him. CT imaging revealed that Kai had a large cerebellar cyst causing compression of the back of his brain along with spinal fluid buildup. There were two possible options for Kai's treatment, to continue long-term medication use or brain surgery to decompress the cyst. Surgery for Kai would potentially be curative although brain surgery also comes with substantial risk. After significant consideration and given Kai's young age, his pet-parents decided to pursue their hope for a cure through surgery and avoid the side effects of long-term medication use.

Dr. Chen-Allen alongside VRCCO's surgeons performed a suboccipital craniectomy on Kai on July 30. Dr. Chen-Allen was able to successfully decompress the cyst and allow the release of spinal fluid. Kai recovered smoothly, with noticeable positive changes within days of returning home. Kai has since presented as neurologically normal and has been weaned off of medication.

This surgery has allowed Kai the chance to live a healthy, fulfilling life. Because of his pet-parent's perseverance and trust in VRCCO Neurology, they can be reassured that they did everything to help Kai and give him the life he deserves. For Dr. Chen-Allen, Kai's story is just the beginning. She is confident that this is only a start to the impact her department can make at VRCCO.

Starting this year, the Veterinary Referral Center of Central Oregon will be one of the few centers in the country to offer pituitary surgery for pituitary tumor resection. This specialized procedure will allow Dr. Chen-Allen to continue pushing the envelope for veterinary neurology in order to provide pets with a chance at attaining the highest quality of life possible.

VRCCO believes that pets and pet-parents deserve the best, most advanced care. Their Neurology service is up for this challenge and is quickly becoming the trusted center for pets with complicated neurologic diseases. Learn more about Kai's personalized experience with VRCCO, click to watch his video story on YouTube, Facebook or Instagram.

Contact Information

Katie Sedivec
Marketing Director
marketing@vrcvet.com
541-209-6960

.

SOURCE: Veterinary Referral Center of Central Oregon



View the original press release on accesswire.com

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.